Clinical Trials
27 trialsRemodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
g-RAMPP
Martini-Klinik am UKE GmbH
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
Zhongda Hospital
AssiutU
Assiut University
MESODEC
University Hospital, Antwerp
3 Tesla MRI in Patients With Bladder Cancer
University of Cincinnati
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study
Peking University First Hospital
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
OHSU Knight Cancer Institute
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors
Tongji Hospital
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
Instituto do Cancer do Estado de São Paulo
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
The First Affiliated Hospital with Nanjing Medical University
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Peking Union Medical College Hospital
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University
POUT
Institute of Cancer Research, United Kingdom
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
University of Maryland, Baltimore
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients
NMP Medical Research Institute
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Fox Chase Cancer Center
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Ann & Robert H Lurie Children's Hospital of Chicago